Table 2. Baseline Characteristics of individuals based on their reason for testing.
| (MISSING)
(N=30095) |
HEALTH
FACILITY A (N=11374) |
MASS
TESTING B (N=28237) |
STUDY_
RELATED C (N=1215) |
AIR
TRAVELLER (N=1293) |
TRUCK
DRIVER D (N=27480) |
TOTAL
(N=99694) |
|
|---|---|---|---|---|---|---|---|
| SEX | |||||||
| (MISSING) | 2390 (7.9%) | 466 (4.1%) | 937 (3.3%) | 76 (6.3%) | 30 (2.3%) | 760 (2.8%) | 4659 (4.7%) |
| FEMALE | 7424 (24.7%) | 4741 (41.7%) | 8940 (31.7%) | 241 (19.8%) | 258 (20.0%) | 218 (0.8%) | 21822 (21.9%) |
| MALE | 20281 (67.4%) | 6167 (54.2%) | 18360 (65.0%) | 898 (73.9%) | 1005 (77.7%) | 26502 (96.4%) | 73213 (73.4%) |
| AGE (YEARS) | |||||||
| (MISSING) | 1222 (4.1%) | 483 (4.2%) | 422 (1.5%) | 85 (7.0%) | 32 (2.5%) | 178 (0.6%) | 2422 (2.4%) |
| >0–20 | 3182 (10.6%) | 1448 (12.7%) | 3615 (12.8%) | 30 (2.5%) | 88 (6.8%) | 330 (1.2%) | 8693 (8.7%) |
| >20–30 | 9392 (31.2%) | 3091 (27.2%) | 7826 (27.7%) | 508 (41.8%) | 370 (28.6%) | 4677 (17.0%) | 25864 (25.9%) |
| >30–40 | 8305 (27.6%) | 2952 (26.0%) | 7476 (26.5%) | 339 (27.9%) | 403 (31.2%) | 10018 (36.5%) | 29493 (29.6%) |
| >40–50 | 4809 (16.0%) | 1759 (15.5%) | 5402 (19.1%) | 164 (13.5%) | 215 (16.6%) | 8496 (30.9%) | 20845 (20.9%) |
| >50 | 3185 (10.6%) | 1641 (14.4%) | 3496 (12.4%) | 89 (7.3%) | 185 (14.3%) | 3781 (13.8%) | 12377 (12.4%) |
| CLINICAL STATUS | |||||||
| MISSING | 0 (0.0%) | 1 (0.0%) | 0 (0.0%) | 1 (0.1%) | 0 (0.0%) | 0 (0.0%) | 2 (0.0%) |
| ASYMPTOMATIC | 29304 (97.4%) | 10421 (91.6%) | 27537 (97.5%) | 1198 (98.6%) | 1278 (98.8%) | 27386 (99.7%) | 97124 (97.4%) |
| SYMPTOMATIC | 791 (2.6%) | 952 (8.4%) | 700 (2.5%) | 16 (1.3%) | 15 (1.2%) | 94 (0.3%) | 2568 (2.6%) |
A Individuals tested in a health facility, BThis covers individuals tested through contact tracing, quarantine and surveillance. C This group represents samples collected for three studies: Chadox, ImmunoCov and IP. Drepresents truck drivers, 112/27480 were tested in a health facility.